Annual EBIT
-$8.04 M
+$1.63 M+16.88%
December 1, 2023
Summary
- As of February 8, 2025, DRMA annual earnings before interest & taxes is -$8.04 million, with the most recent change of +$1.63 million (+16.88%) on December 1, 2023.
- During the last 3 years, DRMA annual EBIT has fallen by -$5.00 million (-164.60%).
- DRMA annual EBIT is now -164.60% below its all-time high of -$3.04 million, reached on December 31, 2020.
Performance
DRMA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.23 M
-$342.00 K-11.86%
September 1, 2024
Summary
- As of February 8, 2025, DRMA quarterly earnings before interest & taxes is -$3.23 million, with the most recent change of -$342.00 thousand (-11.86%) on September 1, 2024.
- Over the past year, DRMA quarterly EBIT has dropped by -$1.01 million (-45.31%).
- DRMA quarterly EBIT is now -801.54% below its all-time high of -$357.80 thousand, reached on December 31, 2020.
Performance
DRMA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.53 M
-$1.41 M-13.97%
September 1, 2024
Summary
- As of February 8, 2025, DRMA TTM earnings before interest & taxes is -$11.53 million, with the most recent change of -$1.41 million (-13.97%) on September 1, 2024.
- Over the past year, DRMA TTM EBIT has dropped by -$3.49 million (-43.41%).
- DRMA TTM EBIT is now -755.17% below its all-time high of -$1.35 million, reached on March 31, 2020.
Performance
DRMA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DRMA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.9% | -45.3% | -43.4% |
| 3 y3 years | -164.6% | -86.2% | -41.2% |
| 5 y5 years | -79.9% | -86.2% | -41.2% |
DRMA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | +16.9% | -88.5% | at low | -53.1% | at low |
| 5 y | 5-year | -164.6% | +16.9% | -801.5% | at low | -755.2% | at low |
| alltime | all time | -164.6% | +16.9% | -801.5% | at low | -755.2% | at low |
Dermata Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.23 M(+11.9%) | -$11.53 M(+14.0%) |
| Jun 2024 | - | -$2.88 M(-10.0%) | -$10.12 M(+12.8%) |
| Mar 2024 | - | -$3.20 M(+44.3%) | -$8.97 M(+11.5%) |
| Dec 2023 | -$8.04 M(-16.9%) | -$2.22 M(+22.5%) | -$8.04 M(+6.7%) |
| Sep 2023 | - | -$1.81 M(+4.6%) | -$7.53 M(-7.8%) |
| Jun 2023 | - | -$1.73 M(-23.9%) | -$8.17 M(-10.9%) |
| Mar 2023 | - | -$2.28 M(+33.1%) | -$9.17 M(-5.3%) |
| Dec 2022 | -$9.67 M | -$1.71 M(-30.0%) | -$9.67 M(-8.0%) |
| Sep 2022 | - | -$2.45 M(-10.4%) | -$10.52 M(+7.5%) |
| Jun 2022 | - | -$2.73 M(-2.0%) | -$9.78 M(+16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.79 M(+9.1%) | -$8.38 M(+6.7%) |
| Dec 2021 | -$7.86 M(+158.5%) | -$2.55 M(+49.1%) | -$7.86 M(+38.8%) |
| Sep 2021 | - | -$1.71 M(+28.7%) | -$5.66 M(+26.1%) |
| Jun 2021 | - | -$1.33 M(-41.2%) | -$4.49 M(+13.6%) |
| Mar 2021 | - | -$2.26 M(+532.1%) | -$3.95 M(+30.0%) |
| Dec 2020 | -$3.04 M(-32.0%) | -$357.80 K(-33.8%) | -$3.04 M(+13.3%) |
| Sep 2020 | - | -$540.10 K(-31.9%) | -$2.68 M(+25.2%) |
| Jun 2020 | - | -$792.80 K(-41.2%) | -$2.14 M(+58.8%) |
| Mar 2020 | - | -$1.35 M | -$1.35 M |
| Dec 2019 | -$4.47 M | - | - |
FAQ
- What is Dermata Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dermata Therapeutics?
- What is Dermata Therapeutics annual EBIT year-on-year change?
- What is Dermata Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly EBIT year-on-year change?
- What is Dermata Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dermata Therapeutics?
- What is Dermata Therapeutics TTM EBIT year-on-year change?
What is Dermata Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DRMA is -$8.04 M
What is the all time high annual EBIT for Dermata Therapeutics?
Dermata Therapeutics all-time high annual earnings before interest & taxes is -$3.04 M
What is Dermata Therapeutics annual EBIT year-on-year change?
Over the past year, DRMA annual earnings before interest & taxes has changed by +$1.63 M (+16.88%)
What is Dermata Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DRMA is -$3.23 M
What is the all time high quarterly EBIT for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly earnings before interest & taxes is -$357.80 K
What is Dermata Therapeutics quarterly EBIT year-on-year change?
Over the past year, DRMA quarterly earnings before interest & taxes has changed by -$1.01 M (-45.31%)
What is Dermata Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DRMA is -$11.53 M
What is the all time high TTM EBIT for Dermata Therapeutics?
Dermata Therapeutics all-time high TTM earnings before interest & taxes is -$1.35 M
What is Dermata Therapeutics TTM EBIT year-on-year change?
Over the past year, DRMA TTM earnings before interest & taxes has changed by -$3.49 M (-43.41%)